Dodecamer repeat expansion in cystatin B gene in progressive myoclonus epilepsy

被引:266
|
作者
Lalioti, MD
Scott, HS
Buresi, C
Rossier, C
Bottani, A
Morris, MA
Malafosse, A
Antonarakis, SE
机构
[1] HOSP BELLE IDEE,DEPT GENET & MICROBIOL,LAB HUMAN MOL GENET,CH-1211 GENEVA,SWITZERLAND
[2] UNIV GENEVA,SCH MED,CH-1211 GENEVA 4,SWITZERLAND
[3] CANTONAL HOSP GENEVA,CH-1211 GENEVA,SWITZERLAND
[4] HOSP BELLE IDEE,DIV NEUROPSYCHIAT,CH-1211 GENEVA,SWITZERLAND
关键词
D O I
10.1038/386847a0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Progressive myaclonus epilepsy of the Unverricht-Lundborg type (EPM1; MIM 254800) is an autosomal recessive disorder with onset between 6 and 13 years followed by variable progression to mental deterioration and cerebellar ataxia(1). It is a rare disorder but more common in Finland (1 in 20,000) and the western Mediterranean(1,2). Two point mutations in the cysteine proteinase inhibitor gene cystatin B (CSTB), proved that this gene is responsible for EPM1 (ref. 3). An extensive search in the CSTB gene revealed mutations accounting only for 14% of the 58 unrelated EPM1 alleles studied(4). Here we report that the majority of EPM1 alleles contain expansions of a dodecamer (12-mer) repeat located about 70 nucleotides upstream of the transcription start site nearest to the 5' end of the CSTB gene. Normal alleles contain 2 or 3 copies of this repeat whereas mutant alleles contain more than 60 such repeats and have reduced levels of CSTB messenger RNA in brood but not in cell lines. 'Premutation' CSTB alleles with 12-17 repeats show marked instability when transmitted to off-spring.
引用
收藏
页码:847 / 851
页数:5
相关论文
共 50 条
  • [31] PROGRESSIVE MYOCLONUS EPILEPSY ASSOCIATED WITH SACS GENE MUTATIONS
    Nascimento, Fabio A.
    Canafoglia, Laura
    Aljaafari, Danah
    Muona, Mikko
    Lehesjoki, Anna-Elina
    Berkovic, Samuel F.
    Franceschetti, Silvana
    Andrade, Danielle M.
    NEUROLOGY-GENETICS, 2016, 2 (04)
  • [32] Progressive Myoclonus Epilepsy: The Gene-Empowered Era
    Minassian, Berge A.
    Striano, Pasquale
    Avanzini, Giuliano
    EPILEPTIC DISORDERS, 2016, 18 : S1 - S1
  • [33] Biochemical and immunohistochemical analysis of cystatin B and cathepsins B, H, L and S in progressive myoclonus epilepsy, EPM1.
    Rinne, R
    Alakurtti, K
    Virtaneva, K
    Saukko, P
    Rinne, A
    Lehesjoki, A
    EPILEPSIA, 1999, 40 : 265 - 265
  • [34] Proteomics studies of progressive myoclonus epilepsy (EPM1) using cystatin B-deficient mice model
    Reeben, M
    Komarovski, V
    Auriola, S
    Arbatova, J
    EPILEPSIA, 2003, 44 : 56 - 56
  • [35] Unstable insertion in the 5′ flanking region of the cystatin B gene is the most common mutation in progressive myoclonus epilepsy type 1, EPM1
    Ronald G. Lafreniére
    Daniel L. Rochefort
    Nathalie Chrétien
    Johanna M. Rommens
    Jeffrey I. Cochius
    Reetta Kälviäinen
    Unto Nousiainen
    George Patry
    Kevin Farrell
    Birgitta Söderfeldt
    Antonio Federico
    Bradford R. Hale
    Otto Hernandez Cossio
    Troels Sørensen
    Marc A. Pouliot
    Tomasz Kmiec
    Peter Uldall
    József Janszky
    Michael R. Pranzatelli
    Frederick Andermann
    Eva Andermann
    Guy A. Rouleau
    Nature Genetics, 1997, 15 : 298 - 302
  • [36] Unstable insertion in the 5' flanking region of the cystatin B gene is the most common mutation in progressive myoclonus epilepsy type 1, EPM1
    Lafreniere, RG
    Rochefort, DL
    Chretien, N
    Rommens, JM
    Cochius, JI
    Kalviainen, R
    Nousiainen, U
    Patry, G
    Farrell, K
    Soderfeldt, B
    Federico, A
    Hale, BR
    Cossio, OH
    Sorensen, T
    Pouliot, MA
    Kmiec, T
    Uldall, P
    Janszky, J
    Pranzatelli, MR
    Andermann, F
    Andermann, E
    Rouleau, GA
    NATURE GENETICS, 1997, 15 (03) : 298 - 302
  • [37] Erratum: Loss of lysosomal association of cystatin B proteins representing progressive myoclonus epilepsy, EPM1, mutations
    Kirsi Alakurtti
    Ekkehard Weber
    Riitta Rinne
    Gerit Theil
    Gerrit-Jan de Haan
    Dick Lindhout
    Paula Salmikangas
    Pekka Saukko
    Ulla Lahtinen
    Anna-Elina Lehesjoki
    European Journal of Human Genetics, 2005, 13 : 264 - 264
  • [38] The expanded dodecamer repeat in Progressive myoclonus epilepsy (EPM1) is unstable, shows no correlation with age of onset, and results in reduced expression of reporter genes in vitro
    Lalioti, MD
    Scott, HS
    Genton, P
    Grid, D
    Ouazzani, R
    M'Rabet, A
    Ibrahim, S
    Gouider, R
    Dravet, C
    Chkili, T
    Bottani, A
    Buresi, C
    Malafosse, A
    Antonarakis, SE
    EUROPEAN JOURNAL OF HUMAN GENETICS, 1998, 6 : 146 - 146
  • [39] DRUG EFFECTS TO THE MYOCLONUS OF PROGRESSIVE MYOCLONUS EPILEPSY
    TATENO, A
    MATSUI, A
    SAKURAGAWA, N
    ARIMA, M
    BRAIN & DEVELOPMENT, 1983, 5 (02): : 233 - 233
  • [40] Mutation in the mitochondrial tRNAIle gene causes progressive myoclonus epilepsy
    Zsurka, Gabor
    Becker, Felicitas
    Heinen, Markus
    Gdynia, Hans-Juergen
    Lerche, Holger
    Kunz, Wolfram S.
    Weber, Yvonne G.
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2013, 22 (06): : 483 - 486